April 21, 2009 - St. Jude Medical Inc. yesterday announced CE mark approval of its AnalyST Accel and Current Accel implantable cardioverter defibrillators (ICDs), which automatically adjust therapy to changing patient needs for increased safety and accelerated follow-up.
